Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

A pathogenesis-associated mutation in human mitochondrial tRNALeu(UUR) leads to reduced 3'-end processing and CCA addition.

Levinger L, Oestreich I, Florentz C, Mörl M.

J Mol Biol. 2004 Mar 26;337(3):535-44.

PMID:
15019775
2.

Human mitochondrial diseases associated with tRNA wobble modification deficiency.

Kirino Y, Suzuki T.

RNA Biol. 2005 Apr;2(2):41-4. Epub 2005 Apr 14. Review.

PMID:
17132941
3.
4.

Human mitochondrial diseases caused by lack of taurine modification in mitochondrial tRNAs.

Suzuki T, Nagao A, Suzuki T.

Wiley Interdiscip Rev RNA. 2011 May-Jun;2(3):376-86. doi: 10.1002/wrna.65. Epub 2011 Feb 25. Review.

PMID:
21957023
5.

Mitochondrial tRNA 3' end metabolism and human disease.

Levinger L, Mörl M, Florentz C.

Nucleic Acids Res. 2004 Oct 11;32(18):5430-41. Print 2004. Review.

6.

Disorders of mitochondrial protein synthesis.

Jacobs HT.

Hum Mol Genet. 2003 Oct 15;12 Spec No 2:R293-301. Epub 2003 Aug 19. Review.

PMID:
12928485
7.

Early onset cardiomyopathy associated with the mitochondrial tRNALeu((UUR)) 3271T>C MELAS mutation.

Brisca G, Fiorillo C, Nesti C, Trucco F, Derchi M, Andaloro A, Assereto S, Morcaldi G, Pedemonte M, Minetti C, Santorelli FM, Bruno C.

Biochem Biophys Res Commun. 2015 Mar 13;458(3):601-4. doi: 10.1016/j.bbrc.2015.01.157. Epub 2015 Feb 11. Review.

PMID:
25680467
8.

Processing of human mitochondrial tRNA(Ser(AGY))GCU: a novel pathway in tRNA biosynthesis.

Rossmanith W.

J Mol Biol. 1997 Jan 31;265(4):365-71. Review.

PMID:
9034356
9.

Molecular pathology of MELAS and L-arginine effects.

Koga Y, Povalko N, Nishioka J, Katayama K, Yatsuga S, Matsuishi T.

Biochim Biophys Acta. 2012 May;1820(5):608-14. doi: 10.1016/j.bbagen.2011.09.005. Epub 2011 Sep 14. Review.

PMID:
21944974
10.

The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Scaglia F, Northrop JL.

CNS Drugs. 2006;20(6):443-64. Review. Erratum in: CNS Drugs. 2008;22(1):81.

PMID:
16734497
11.

A story with a good ending: tRNA 3'-end maturation by CCA-adding enzymes.

Xiong Y, Steitz TA.

Curr Opin Struct Biol. 2006 Feb;16(1):12-7. Epub 2005 Dec 20. Review.

PMID:
16364630
12.

Human mitochondrial transfer RNAs: role of pathogenic mutation in disease.

Scaglia F, Wong LJ.

Muscle Nerve. 2008 Feb;37(2):150-71. Review.

PMID:
17999409
13.

The np 3243 MELAS mutation: damned if you aminoacylate, damned if you don't.

Jacobs HT, Holt IJ.

Hum Mol Genet. 2000 Mar 1;9(4):463-5. Review.

PMID:
10699169
14.

Molecular investigations on tRNAs involved in human mitochondrial disorders.

Florentz C.

Biosci Rep. 2002 Feb;22(1):81-98. Review.

PMID:
12418552
15.

Impact of disease-related mitochondrial mutations on tRNA structure and function.

Wittenhagen LM, Kelley SO.

Trends Biochem Sci. 2003 Nov;28(11):605-11. Review.

PMID:
14607091
16.
17.

Transfer RNA and human disease.

Abbott JA, Francklyn CS, Robey-Bond SM.

Front Genet. 2014 Jun 3;5:158. doi: 10.3389/fgene.2014.00158. eCollection 2014. Review.

18.

The CCA-adding enzyme: A central scrutinizer in tRNA quality control.

Betat H, Mörl M.

Bioessays. 2015 Sep;37(9):975-82. doi: 10.1002/bies.201500043. Epub 2015 Jul 14. Review.

PMID:
26172425
19.

[Mitochondrial tRNA diseases: defect of modification in anticodon in mutant tRNA molecules].

Ohta S.

Tanpakushitsu Kakusan Koso. 2003 Mar;48(4 Suppl):493-500. Review. Japanese. No abstract available.

PMID:
12696159
20.

tRNA-nucleotidyltransferases: highly unusual RNA polymerases with vital functions.

Vörtler S, Mörl M.

FEBS Lett. 2010 Jan 21;584(2):297-302. doi: 10.1016/j.febslet.2009.10.078. Review.

Supplemental Content

Support Center